At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Feb 23, 2026 at 19:00 ET
Two C-suite executives at Caribou Biosciences, the Chief Business Officer and Chief Medical Officer, sold shares worth approximately $15.7K in the past week. Both also acquired 45,000 and 55,000 shares, respectively, at $0, likely through option exercises or grants. The net activity reflects minimal monetary selling, suggesting routine portfolio management rather than a negative signal.
- Chief Business Officer Khan Ruhi Ahmad sold 6,938 shares for $13,598.48 at $1.96 per share on 2026-02-24
- Chief Medical Officer Tina M. Albertson sold 1,066 shares for $2,089.36 at $1.96 per share on 2026-02-24
- Both executives acquired large blocks of shares (45,000 and 55,000) at $0 on 2026-02-20, likely via option exercise or vesting
- Total net proceeds from sales: ~$15,688
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access